Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

To evaluate and compare the effects of PEG-400 based artificial tear and Systane tears in mild-moderate dry eye patients. TBUT, Visual impact and subjective evaluations will be assessed in this month long trial.

Inclusion Criteria:

• Patient reported dry eye symptoms (episodic, annoying, activity limiting), SES OD.
• Physician assessment of mild-moderate dry eye
• Patient willing to instill drops QID and complete entire length of protocol.
• TBUT < 10 seconds
• BCVA of 20/30 or better

Exclusion Criteria:

• Current topical cyclosporine use (Restasis)
• Current Systane use
• Refractive surgery within the last 6 months
• Oral or topical corticosteroid use
• Severe dry eye patients by physician assessment
• current active Blepharitis
• Oral Doxycyclines use
• Oral Antihistamine use